期刊文献+

冠心病心绞痛患者血浆白细胞介素-6和超敏C-反应蛋白变化及其临床意义 被引量:3

Changes and clinical relevance of plasma interleukin-6 and high sensitive C-reactive protein in patients with coronary heart disease and angina
原文传递
导出
摘要 目的 探讨白细胞介素-6(IL-6)及超敏C-反应蛋白(hsCRp)在冠心病心绞痛发病机制中的作用.方法 选择冠状动脉造影确诊的心绞痛患者150例,分为不稳定型心绞痛(UAP)组78例,稳定型心绞痛(SAP)组72例,50例冠状动脉造影正常者作为对照组.采用酶联免疫吸附(ELISA)法检测血浆IL-6、免疫浊度法检测hsCRp水平.结果 UAP组血浆IL-6、hsCRP含量为(36.98±9.35)pg/L、(2.25±0.73)μg/L,显著高于SAP组的(23.19±7.35)pg/L和(1.88±0.68)μg/L(P均<0.01),2组IL-6、hsCRP均明显高于对照组(16.93±6.15)pg/L、(1.28±0.40)μg/L(P均<0.01).相关分析表明IL-6与hsCRP正相关,相关系数r=0.875(P<0.05).结论 炎症反应可能参与冠心病的发病过程,血浆IL-6与hsCRP对预测冠心病心绞痛的存在和发展有重要的临床意义. Objective To explore the roles of interleukin-6 (IL-6) and high sensitive C-reactive protein (hsCRP) in coronary heart disease (CHD). Methods One hundred and fifty patients diagnosed as angina pectoris by coronary angiography were enrolled and randomly divided into unstable angina pectoris group ( UAP group n =78) and stable angina group (SAP group n =72). At the same time,50 cases with normal coronary angiography were selected as control. The plasma level of IL-6 was measured by ELISA, and hsCRP was measured by immunonephelometry. Results The mean plasma levels of IL-6 and hsCRP were significantly higher in UAP group compared with SAP group ( IL-6 ( 36. 98 ± 9. 35 ) pg/L vs. ( 23.19 ± 7. 35 ) pg/L; hsCRP ( 2. 25 ± 0. 73 ) μg/Lvs 1.88 ± 0. 68 ) μg/L; P 〈 0. 01 respectively), both were significantly higher than those of control group ( IL-6 (16. 93 ± 6. 15 )pg/L and hsCRP (1.28 ± 0.40)μg/L,P 〈0.01 respectively). We also found significantly positive relationship between IL-6 and hsCRP plasma level ( r = 0. 875, P 〈 0. 05 ). Conclusions Inflammatory response might play an important role in CHD. IL-6 and hsCRP were of high value in prediction of angina pectoris and development of CHD.
出处 《中国综合临床》 2010年第12期1274-1276,共3页 Clinical Medicine of China
基金 河北省邯郸市科学技术研究与发展计划项目(072317099)
关键词 冠心病 心绞痛 白细胞介素-6 C-反应蛋白质 Coronary heart disease Angina pectoris Interleukin-6 High sensitive C-reactive protein
  • 相关文献

参考文献12

二级参考文献28

  • 1程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:87
  • 2Bayes-Genis A,Conver CA,Overgaard MT,et al.The insulin like growth factor axis.Circulation Research,2000,86:125.
  • 3Heeschen C,Dimmeler S,Hamm CW,et al.Soluble CD40 ligand in actue coronary syndromes.N Engl J Med,2003,48:1104-1111.
  • 4Lund J,Qin QP,Ilva T,et al.Pregnancy associated plasma protein-A:abiomarker in acute ST elevation myocardial infarction(STEMI).Ann Med,2006,38:221-228.
  • 5Pedersen TR,Kjekshus J,Berg K,et al.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastain Survival Study (4S).1994.Atheroscler (Suppl),2004,5:81-87.
  • 6Colhoun HM,Betteridge DJ,Durrington PN,et al.Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Colaborative Atorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled trial.Lancet,2004;364:685-696.
  • 7Perticone F,Ceravolo R,Pujia A,et al.Prognostic significance of endothelial dysfunction in hyper5tensive patients.Circulation,2001,104:191-196.
  • 8Pasceri V,Patti G,Nusca A,et al.Randomized trial trial of atorvastatin for reduction of myocardial damage during coronary intervention:results from the ARMYDA study.Circulation,2004;110:674-678.
  • 9Macin SM,Perna ER,Faras EF,et al.Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome:results of a randomized,double-blind,placebo-controlled study.Am Heart J,2005;149:451-457.
  • 10Lund J,Qin QP,Ilva T,et al.Porela P Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation.Circulation,2003,108:1924-1926.

共引文献88

同被引文献31

  • 1何奔,丁嵩,卜军,刘建平,宋玮,杜勇平,沈节艳,金叔宣,孙瑜,沈珑.脑利钠肽和C-反应蛋白在急性冠状动脉综合征介入治疗患者的预后价值[J].中华心血管病杂志,2006,34(4):349-352. 被引量:56
  • 2陈晶晶,文美,毛华,刘庭筑.IL-8及Ps在冠心病患者介入治疗后不同时期变化的研究[J].贵州医药,2006,30(10):885-887. 被引量:2
  • 3张捷,刘迪,胡晓舟,李国权.糖尿病患者血清超敏C反应蛋白与动脉粥样硬化的关系[J].中国误诊学杂志,2007,7(9):1925-1927. 被引量:4
  • 4Shanik MH, Xu Y, Skrha J, et al. Insulin resistance andhyperinsulinemia: is hyperinsulinemia the cart or the horse [J].Diabetes Care,2008,31 Suppl 2:S262-268.
  • 5Nilsson D, Wackenfors A, Oustafsson L, et al. PKC and MAPKsignalling pathways regulate vascular endothelin receptor expression[J]. Eur J Pharmacol,2008,580(1-2) :190-200.
  • 6Yoon YW, Kang TS, Lee BK, et al. Pathobiological role ofadvanced glycation endproducts via mitogen-activated proteinkinase dependent pathway in the diabetic vasculopathy [J]. ExpMol Med,2008,40(4) :398-406.
  • 7Kim JA, Yeh DC, Ver M, et al. Phosphorylation of Ser24 in thepleckstrin homology domain of insulin receptor substrate-1 byMouse Pelle-like kinase/ interleukin-1 receptor- associated kinase :cross-talk between inflammatory signaling and insulin signaling thatmay contribute to insulin resistance [J]. JBiol Chem,2005,280(24):23173-23183.
  • 8Gupta A,Ten S,Anhalt H. Serum levels of soluble tumor necrosisfactor-alpha receptor 2 are linked to insulin resistance and glucoseintolerance in children [J]. J Pediatr Endocrinol Metab,2005,18(1):75-82.
  • 9Alexandraki K,Piperi C,Kalofoutis C,et al. Inflammatory processin type 2 diabetes: The role of cytokines [ J ]. Ann N Y Acad Sci,2006,1084:89-117.
  • 10Fagerberg B,Behre CJ, Wikstrand J, et al. C-reactive protein andtumor necrosis factor-alpha in relation to insulin-mediated glucoseuptake,smoking and atherosclerosis [ J ] ? Scand J Clin Lab Invest,2008,68(7) :534-541.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部